Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant
1 clinical trials · Condition
◉ Watch Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant
| Record | Firm | Date |
|---|---|---|
| Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM (NCT02428660) | Genelex Corporation | 2015-02-01 |
Track Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant automatically
Every clearance here is in the API, with alerts when new ones post.